Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Type: Health professional risk communication
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 61 - 75 of 119 items.
Authorization of Moderna COVID-19 Vaccine with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2020-12-23
Bacitracin for Injection (50,000 IU per vial) and the Risk of Nephrotoxicity and Anaphylactic Reactions
AlertHealth professional risk communication | 2020-12-21
Authorization of Bamlanivimab with English-only Labels for Use in Relation to the COVID-19 Pandemic
AlertHealth professional risk communication | 2020-12-18
ELMIRON (pentosan polysulfate sodium) and the Risk of Pigmentary Maculopathy
AlertHealth professional risk communication | 2020-12-15
Authorization of Pfizer-BioNTech COVID-19 Vaccine with English-only Carton and Vial Labels
AlertHealth professional risk communication | 2020-12-12
Importation of US-labelled Dexrazoxane for Injection distributed by Mylan Pharmaceuticals ULC due to shortage of Canadian-labelled Dexrazoxane
AlertHealth professional risk communication | 2020-12-01
PICATO (ingenol mebutate gel, 0.015% and 0.05%) - Product Withdrawal in Canada due to Potential Increased Risk of Skin Cancer
AlertHealth professional risk communication | 2020-10-27
Benzocaine-Containing Products and the Risk of Methemoglobinemia in Children under Two Years of Age
AlertHealth professional risk communication | 2020-10-22
FIBRISTAL (ulipristal acetate tablets, 5 mg) - Voluntary Withdrawal in Canada due to Risk of Drug-Induced Liver Injury
AlertHealth professional risk communication | 2020-09-30
Importation of US Clinical Trial-Labelled Remdesivir for Injection Due to Shortage of Canadian-Labelled Remdesivir
AlertHealth professional risk communication | 2020-09-15
ESBRIET (pirfenidone) and the Risk of Drug-Induced Liver Injury
AlertHealth professional risk communication | 2020-09-14
Prescription Cough and Cold Products Containing Opioids and the Risk of Opioid Use Disorder in Children and Adolescents (< 18 years of age)
AlertHealth professional risk communication | 2020-08-24
Methadone Treatment of Opioid Dependence and Potential Risk of Lack of Effect when Switching between Different Products
AlertHealth professional risk communication | 2020-07-17
NARDIL (phenelzine sulfate) Shortage
AlertHealth professional risk communication | 2020-06-24
MabCampath (alemtuzumab) - Risk of Haemophagocytic Lymphohistiocytosis, Stroke (including ischaemic and haemorrhagic stroke), and Glomerulonephritis
AlertHealth professional risk communication | 2020-06-22